Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Smoking Cessation 2Weight Gain 1Neoplasms 1Lymphoma 1Heart Failure 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Trastuzumab 625Paclitaxel 576Cyclophosphamide 555Docetaxel 484Capecitabine 401Letrozole 376Fulvestrant 326Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 184Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 138Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Secondary Prevention × Clear all
NCT05892146 2023-06-07

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

National Cheng-Kung University Hospital

Phase NA Unknown
100 enrolled
BreastLymphoid

Breast Neoplasms, Heart Failure, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡